Bioquell Share Discussion Threads

[bountyhunter] 15/7/2004 13:41

games, yes good point, MRSA is now clearly also becoming a growing problem outside of hospitals in the US:
(link provided by MBDRIVER on the ETQ thread) -


I imagine that this must make it even more important to reduce the MRSA levels in hospitals to prevent it's spread into the community.

[games] 15/7/2004 09:22

btw. mrsa is hitting the news in the US, apparently spreading outside hospitals, with the litigation society over there companies will have to act, to at least show the court that they have done all that is possible. Interestingly bqe in their recent reports are very bullish about the US, and mention that the US postal anthrax incident is estimated to have cost the US $200m, but at that time bqe's solution was not available.

[scotswhaehae] 15/7/2004 08:28

Pleasing to see this one rising at last....long overdue....and still very undervalued.

[bountyhunter] 15/7/2004 08:10

heading north already again today!

[furhaan] 14/7/2004 13:53

some big buys coming in, but above the offer price for some reason? Anyone know why>

[bountyhunter] 14/7/2004 12:31

i only bought bqe and ntp first thing yesterday morning and am well up on both already!
(bought etq on Monday and am down on that one but it seems to be already resuming the uptrend today)

Here is today's full RNS for quick reference:

14 July 2004
BIOQUELL PLC

Announces its first "superbug" bio-decontamination
in a European hospital

BIOQUELL PLC ("BIOQUELL") announces that it has successfully completed its first
"superbug" bio-decontamination contract in two Intensive Care Units in a
hospital in France, using its recently launched Room Bio-Decontamination Service
("RBDS"). This is the first time that BIOQUELL's unique bio-decontamination
service has been sold into a hospital in Europe to combat hospital acquired
infection.

BIOQUELL notes the comments made earlier today by the Government in response to
the National Audit Office report into Hospital Acquired Infection and looks
forwards to working with the NHS and the Department of Health in assisting with
combating hospital acquired infection in the UK.

Further information

Earlier this year a research paper jointly written by BIOQUELL, King's College
London and Guy's and St Thomas' Hospital (following a four year joint R&D
programme) was published in the Journal of Hospital Infection. This research
showed, in summary, that:

(i) a high level of MRSA contamination was found in the environment in
the hospital;
(ii) conventional cleaning methods were not effective against MRSA; and
(iii) BIOQUELL's RBDS bio-decontamination technology was dramatically
effective against MRSA.

- Ends -

+ link to national audit report entitled "Improving patient care by reducing the risk of hospital acquired infection: a progress report" out today


+ link to hospital league tables (re infection stats) also published today:

[furhaan] 14/7/2004 12:28

lets hope!
i hold both bqe and etq but not ntp think its too high already!

[bountyhunter] 14/7/2004 12:27

yes this could see the same type of dramatic rise that etq and ntp have seen recently when today's news gets further publicity!

[furhaan] 14/7/2004 12:22

hopefully get a second wave today as it becomes public knowledge

[furhaan] 14/7/2004 12:20

should generate a decent amount of interest really

[bountyhunter] 14/7/2004 12:11

Great news out today:
LONDON (AFX) - Bioquell PLC said it has successfully completed its first
"superbug" bio-decontamination contract in two Intensive Care Units in a
hospital in France, using its recently launched Room Bio-Decontamination Service
(RBDS).
This is the first time that BIOQUELL's unique bio-decontamination service
has been sold into a hospital in Europe to combat hospital acquired infection.

[games] 14/7/2004 12:09

Cal, I think it had been up 5p for a while earlier, and imo a lot of the recent small rises were due to the fact that mrsa were headlines, with the Gov proposals etc etc known to be due.

Anyhow i hope the kit is widely deployed, and does have a positive effect on reducing the amount of innocent folk blighted by mrsa.

[furhaan] 14/7/2004 12:03

what do u mean calleva?

[calleva] 14/7/2004 12:00

News seems to have leaked half hour earlier!

[games] 14/7/2004 11:49

Nice rns just out. Some profit taking to be expected. Looking to the US for further news, especially with the funding (over $5b) that was announced yesterday to combat bio/nuke infections/threats, and bqe already have contracts.

[bountyhunter] 13/7/2004 08:52

I'm invested in BQE, and also NTP and ETQ; all three companies have products / drugs which will be important in the fight against MRSA imho.

[bountyhunter] 13/7/2004 08:49

Website:





Bioquell is the world leader in bio-decontamination equipment and services. Hydrogen peroxide vapour (HPV) bio-decontamination technology is used to eradicate problematic bacteria, viruses and fungi. Filtration systems are used to combat chemical, biological, radiological and nuclear (CBRN) contamination.

24 July 2018 - Interims
Commenting on the 2018 interim results, Ian Johnson, Executive Chairman of Bioquell PLC, said:

"I am pleased to report continued growth in revenues despite exchange rate headwinds, a strong comparative first half in 2017 and the effect of disposals. Our core business increased by 15% on like for like sales at constant currency. Profit before tax increased by 41% with further improvement in gross margins from 52% to 54%.

The final non-core asset disposal of MDH Defence (which will cease to generate revenue from the end of 2018) provides the business with more predictable revenues and higher quality earnings from bio decontamination solutions and modular isolators. Given the continued improvements, particularly with respect to profitability, the Board believes that the Company will exceed current market expectations for profit for the full year."


30 November 2018

RECOMMENDED CASH OFFER

for

Bioquell plc ("Bioquell" or the "Company")

-- The boards of Ecolab and Bioquell are pleased to announce that they have reached agreement on the terms of a recommended cash offer to be made by Ecolab Offeror for the entire issued and to be issued ordinary share capital of Bioquell (the "Offer"). The Offer is to be effected by means of a Court--sanctioned scheme of arrangement under Part 26 of the Companies Act.


-- Under the terms of the Offer, Bioquell Shareholders shall be entitled to receive:
for each Scheme Share : 590 pence in cash.
-- The Offer values the entire issued and to be issued ordinary share capital of Bioquell at approximately GBP140.51 million and represents:

o a premium of approximately 40.48 per cent. to the Closing Price of 420 pence per Bioquell Share on 29 November 2018 (being the last Business Day before the commencement of the Offer Period).



16 January 2019
RECOMMED CASH ACQUISITION

of

Bioquell PLC ("Bioquell" or the "Company")

by

Ecolab U.S. 2 Inc. ("Ecolab Offeror"), a wholly-owned subsidiary of Ecolab Inc. ("Ecolab")

Scheme of Arrangement becomes Effective

On 30 November 2018, the boards of Bioquell and Ecolab Offeror, a wholly-owned subsidiary of Ecolab, announced that they had reached agreement on the terms of a recommended cash acquisition by which the entire issued and to be issued ordinary share capital of Bioquell would be acquired by Ecolab Offeror (the "Acquisition"). The Acquisition is to be effected by means of a Court approved scheme of arrangement under Part 26 of the Companies Act 2006 (the "Scheme").

On 14 January 2019, Bioquell and Ecolab Offeror announced that the Court had sanctioned the Scheme.

Bioquell and Ecolab Offeror are pleased to announce that the Scheme has now become effective.

Under the terms of the Scheme, the holders of Scheme Shares are entitled to receive 590 pence for each Scheme Share held at the Scheme Record Time, being 6.00 p.m. (London time) on 15 January 2019. The latest date for the dispatch of cheques to Scheme Shareholders and settlement through CREST is as soon as practicable after today's date, and in any event within 14 days of today's date.

Dealings in Bioquell Shares were suspended with effect from 6.00 p.m. (London time) on 15 January 2019. Applications have been made to the UK Listing Authority and the London Stock Exchange in relation to the delisting of Bioquell Shares from the Official List of the UK Listing Authority and the cancellation of the admission to trading of Bioquell Shares on the Main Market for listed securities of the London Stock Exchange, which are each expected to take effect from 8.00 a.m. (London time) on 17 January 2019.

[games] 30/6/2004 10:59

MRSA fears after secret testing

[games] 29/6/2004 15:51

Director purchase....Resonable recent movement...chart looking interesting....and the odd nice trade today.

edit...should be recent director purchase.

[peedlep] 01/6/2004 09:03

Anyone going to the AGM today?

[jeff24] 19/5/2004 10:52

Last month's good research news, wearing off now, wonder how far it will fall?

[shiny000] 26/4/2004 01:43

A new hero in the battle against superbugs

[onehanded] 22/4/2004 11:29

Sold 2,500 shares this am and so now fully out. Going to top up on half mdw and mtna. Great profit but took a year to get it. Love the look of MTNA. Good luck holders and hope you do well.

[onehanded] 22/4/2004 07:09

Hey still got 25% of my original stock I never sold. Looking to sell tomorrow, on another day of gains. Going to get into another small company about to go up big time. USA company called Material Techo MTNA. Worth a look at. Told you this was a buy and now switching into another gem. Again will need to sit tight for up to a year to collect the real gains.